Invictus MD Moves To TSX Venture Exchange

Posted on Categories: Investor Relations

VANCOUVER, BC, March 30, 2017 – INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s cannabis company, is pleased to announce that its common shares will be delisted from the Canadian Securities Exchange after the close of trading on March 30, 2017 and will be listed on the TSX Venture Exchange (“TSXV“) commencing at the open of trading on March 31, 2017. There will be no interruption in trading and the Company’s trading symbol “IMH” will remain the same.

Read more “Invictus MD Moves To TSX Venture Exchange”

Invictus MD Announces OptionCo Has Received its License to Cultivate under ACMPR

Posted on Categories: Investor Relations

Vancouver, BC, March 30, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that OptionCo has received its license to cultivate under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) as Acreage Pharms Ltd. (“Acreage Pharms”).

Read more “Invictus MD Announces OptionCo Has Received its License to Cultivate under ACMPR”

Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market

Posted on Categories: Investor Relations

VANCOUVER, BC, March 28, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to provide an update of its production capability in preparation for the recreational cannabis market.

Read more “Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market”